Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Closantel is a salicylanilide small molecule anthelmintic primarily used in veterinary medicine to treat parasitic infections in livestock such as cattle, sheep, and goats. It is particularly effective against trematodes, including the liver fluke *Fasciola hepatica*, as well as certain nematodes like *Haemonchus contortus* and arthropod larvae. The drug exerts its antiparasitic effect by uncoupling oxidative phosphorylation in the mitochondria of the parasite, which disrupts ATP production and leads to metabolic exhaustion and death. Aarambh Life Science manufactures closantel as a generic active pharmaceutical ingredient (API) in both base and sodium salt forms for use in various veterinary formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on closantel.